Boeing may deliver Dreamliner 787 to Air India next week

September 20, 2012
Los Angeles, September 20: Boeing Co plans to deliver the first Dreamliner 787 made in South Carolina next week, a jet equipped with an engine model that recently experienced failures and has drawn federal scrutiny.

The North Charleston-built jet, for Air India, is "ticketed" and certified by the Federal Aviation Administration, which means it is ready for delivery, a Boeing official said on Wednesday. Its General Electric Co GEnx engines also have undergone special inspection, the official said, after the failures raised concerns.

Delivery from the second Boeing plant to make Dreamliners marks an important milestone for a jet that has been beset by assembly problems that caused huge cost overruns and delays.

Carbon composites that replaced aluminum on the jet reduced its weight and cut fuel consumption 20% compared with other planes its size on similar routes - savings prized by airline customers eager to tame soaring fuel bills. But the delays have damaged Boeing's credibility with customers, making the first delivery from the second line all the more meaningful. The engine problems could have caused further delays.

The special engine inspections came after recent incidents in two Boeing 787s in which the fan midshaft on General Electric GEnx-1B engines fractured or showed cracks. On September 14, the National Transportation Safety Board recommended immediate safety inspections.

One of the incidents took place in July at Charleston International Airport when debris from the engine of a Boeing 787 sparked a grass fire near the runway where it was taxiing.

Earlier Wednesday, the FAA told Reuters it would stop short of issuing an emergency directive on the engines, sticking instead to more routine safety notices.

"We have done the checks on all our GE engines," Jack Jones, vice president and general manager of Boeing South Carolina, said Wednesday at an international trade conference near Charleston.

"We're clear and we're good," he told Reuters. "GE has done a great job of figuring out quickly what we have to do to ensure the integrity of the engine. We know that and we've implemented it."

Jones said the engine issue had not affected its schedule of delivering planes. "It obviously didn't stop deliveries. That is absolutely critical."

"Trust me, with GE, FAA, regulatory, Boeing, we would never have let that engine go on an airplane if we even slightly suspected it. So we know it's safe." He said the plane maker "is in probably one of the most highly regulated industries in the U.S."

The plane was finished and the planned delivery next week was timed to suit the customer, Jones said.

Two 787s built at Boeing's Everett, Washington, plant have already been delivered to Air India - one earlier this month and one on Tuesday, both from the South Carolina facility.

Boeing South Carolina, which is currently building a 787 widebody jet every 18 days at its North Charleston final assembly plant, has 6,100 employees including about 200 on the flight line, Jones said.

The production rate will rise to three-and-a-half airplanes a month "later," Jones said. The plant also builds 787 aft fuselages for Boeing's Puget Sound final assembly plant.

"Not just here in South Carolina but in Puget Sound, we're all really focused on production rate because the production rates in several of our plants are going up to unprecedented levels," he said.

Boeing shares fell 0.8% to close at USD 69.90 on the New York Stock Exchange on Wednesday.

Boeing_787-8_Air-India



Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 20,2020

Langkawi, Jan 20: Malaysia will not take retaliatory trade action against India over its boycott of palm oil purchases amid a political row between the two countries, Prime Minister Mahathir Mohamad said on Monday.

India, the world’s largest edible oil buyer, this month effectively halted imports from its largest supplier and the world’s second-biggest producer in response to comments from Mahathir attacking India’s domestic policies.

“We are too small to take retaliatory action,” Mahathir told reporters in Langkawi, a resort island off the western coast of Malaysia. “We have to find ways and means to overcome that,” he added.

The 94-year-old premier of Muslim-majority Malaysia has criticised New Delhi’s new religion-based citizenship law and also accused India of invading the disputed region of Kashmir.

Mahathir again criticised India’s citizenship law on Monday, saying he believed it was “grossly unfair”.

India has been Malaysia’s largest palm oil market for the past five years, presenting the Southeast Asian country with a major challenge in finding new buyers for its palm oil.

Benchmark Malaysian palm futures fell nearly 10% last week, their biggest weekly decline in more than 11 years.

New Delhi is also unhappy with Malaysia’s refusal to revoke permanent resident status for controversial Indian Islamic preacher Zakir Naik, who has lived in Malaysia for about three years and faces charges of money laundering and hate speech in India.

Mahathir said even if the Indian government guarantees a fair trial, Naik faces the real threat of vigilante action and that Malaysia will only relocate the preacher if it can find a third country where he would be safe.

“If we can find a place for him, we will send him out.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Paris, Apr 10: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.

The company has already doubled its incremental production capacity on top of the usual production for current indications across its eight hydroxychloroquine manufacturing sites worldwide and is on track to quadruple it by the summer.

"In this global health emergency, Sanofi stands ready to assist as many countries as possible, starting with countries where its medicine is registered for current approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations," it said in a statement.

Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.

"The COVID-19 pandemic is an unprecedented health and economic crisis which is shaking some of the very fundamentals of international solidarity and cooperation among countries," said Chief Executive Officer Paul Hudson. "This virus does not care about the concept of borders, so we should not either," he added.

"It is critical that international authorities, local governments, manufacturers and all other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it. If the trials prove positive, we hope our donation will play a critical role for patients," said Hudson.

While hydroxychloroquine is generating a lot of hope for patients around the world, said Sanofi, it should be remembered that there are no results from ongoing studies and the results may be positive or negative.

To date, there is insufficient clinical evidence to draw any conclusion over the safety and efficacy of hydroxychloroquine in the management of COVID-19 patients.

It is one of several medicines being investigated by the World Health Organisation (WHO) in its international clinical trial seeking a treatment solution for COVID-19. "Sanofi is supporting ongoing trials by providing the medicine to some participating investigator sites and other independent research centres," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 4,2020

Kolkata, Feb 4: A Thailand national on Tuesday gave birth during a flight from Doha to Bangkok.

The unnamed woman passenger went into labour and delivered the baby with the help of a cabin crew of Qatar airways at around 3 am.

The aircraft made the emergency landing in Kolkata and the woman was admitted to a private hospital here. Both the mother and the baby are doing fine.

"An unscheduled flight from Doha to Bangkok QR-830 landed around 03:09 am at Kolkata airport in medical priority landing. The pilot of Qatar flight had asked SOS to ATC for medical priority landing. The flight landed safely, the airport team with the doctor was attending the concerned." Kolkata Airport official said while speaking to news agency.

More details in this regard are awaited.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.